...
机译:miR-206作为溃疡性结肠炎中梅萨明胺治疗的生物标志物。
Division of Gastroenterology Department of Medicine Rutgers Robert Wood Johnson Medical School;
Division of Gastroenterology Department of Medicine Rutgers Robert Wood Johnson Medical School;
Division of Gastroenterology Department of Medicine Rutgers Robert Wood Johnson Medical School;
Department of Pathology and Laboratory Medicine Rutgers Robert Wood Johnson Medical School New;
Rutgers Cancer Institute of New Jersey New Brunswick NJ USA;
Department of Pathology and Laboratory Medicine Rutgers Robert Wood Johnson Medical School New;
Division of Gastroenterology Department of Medicine Rutgers Robert Wood Johnson Medical School;
Division of Gastroenterology Department of Medicine Rutgers Robert Wood Johnson Medical School;
机译:miR-206作为溃疡性结肠炎中梅萨明胺治疗的生物标志物。
机译:用于治疗轻度至中度溃疡性结肠炎的多基质系统(MMX?)美沙拉敏。
机译:MMX美沙拉敏:一种新颖的大剂量,每日一次的5-氨基水杨酸酯制剂,用于治疗溃疡性结肠炎。
机译:基于三维建模和成像优化的溃疡性结肠炎治疗中梅奈胺疗效的大数据分析
机译:溃疡性结肠炎的治疗方案。
机译:细胞运输中的遗传变异不会影响溃疡性结肠炎中美沙拉敏的反应
机译:教师意见建议转录血液生物标志物的有用性作为溃疡性结肠炎粘膜愈合和内镜反应的非侵入性替代标志物。